Product Information

ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Bionpharma Inc., priced at $0.5917 per EA under NDC 69452035325. Its NADAC has been published 45 times since Jan 14, 2026.

FDA first approved this application on Sep 18, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACAMPROSATE CALC DR 333 MG TAB

Acamprosate Calcium
$0.5917per EA

Strength

333 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452035325

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACAMPROSATE CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA219904

FDA Approved

9/18/2025

TE Code

AB

On Market Since

12/1/2025

Price Statistics

The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 45 times since Jan 14, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.5917 per EA
All-time high$0.6218 (Feb 11, 2026)
All-time low$0.5859 (Oct 21, 2026)
52-week high$0.6218
52-week low$0.5859
Median price$0.6077
Average price$0.6045
Largest weekly change+4.0% (Jan 21, 2026)
Weeks tracked45
Tracking sinceJan 14, 2026

Price History

1W

+1.0%

1M

+1.0%

3M

-3.1%

6M

+0.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Bionpharma Inc., is $0.5917 per EA (NDC 69452035325), effective Nov 18, 2026.

How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?

Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Jan 14, 2026.

What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?

Since Jan 14, 2026, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.5859 (Oct 21, 2026) to a high of $0.6218 (Feb 11, 2026), with a median of $0.6077 per EA.

Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACAMPROSATE CALC DR 333 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ACAMPROSATE CALC DR 333 MG TAB?

ACAMPROSATE CALC DR 333 MG TAB (NDC 69452035325) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.